RhumbLine Advisers’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-173,500
Closed -$4.76M 2915
2016
Q3
$4.76M Buy
173,500
+8,823
+5% +$242K 0.01% 912
2016
Q2
$3.59M Buy
164,677
+16,501
+11% +$360K 0.01% 1003
2016
Q1
$3.31M Sell
148,176
-4,616
-3% -$103K 0.01% 1069
2015
Q4
$4.22M Buy
152,792
+1,482
+1% +$41K 0.01% 907
2015
Q3
$3.9M Buy
151,310
+9,452
+7% +$244K 0.01% 934
2015
Q2
$3.52M Sell
141,858
-13,059
-8% -$324K 0.01% 1057
2015
Q1
$3.9M Buy
154,917
+1,271
+0.8% +$32K 0.01% 974
2014
Q4
$3.6M Buy
153,646
+6,520
+4% +$153K 0.01% 977
2014
Q3
$3.35M Buy
147,126
+70
+0% +$1.59K 0.01% 984
2014
Q2
$3.6M Buy
147,056
+6,971
+5% +$170K 0.01% 981
2014
Q1
$2.95M Sell
140,085
-4,940
-3% -$104K 0.01% 1106
2013
Q4
$3.45M Sell
145,025
-11,755
-7% -$280K 0.01% 1023
2013
Q3
$3.35M Sell
156,780
-800
-0.5% -$17.1K 0.01% 1028
2013
Q2
$3.14M Buy
+157,580
New +$3.14M 0.01% 1038

Other funds holding QGENF

RhumbLine Advisers's QGENF Position: Q4 2016 in Review

RhumbLine Advisers sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 173,500 shares — an estimated $4.76M sold.

RhumbLine Advisers first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $4.76M in Q3 2016. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

  • RhumbLine Advisers reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
  • RhumbLine Advisers sold 173,500 QIAGEN NV shares in Q4 2016, an estimated $4.76M.
  • RhumbLine Advisers first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
  • RhumbLine Advisers's QIAGEN NV position peaked at $4.76M in Q3 2016.
  • 189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.